Business Wire

Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs

Jaa

Aprecia Pharmaceuticals, LLC (“Aprecia”), The 3DP Pharmaceutical Company, and Cycle Pharmaceuticals, Ltd. (“Cycle”) today announced they have signed a partnership agreement to develop and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology. The planned products will deliver quality-of-life improvements versus existing, approved orphan drugs, and will achieve this by utilizing Aprecia’s proprietary 3DP ZipDose® Technology platform. ZipDose® is the only three-dimensional printing technology used in a pharmaceutical drug product approved by the U.S. Food and Drug Administration.

Antonio Benedetti, CEO of Cycle commented: “Many rare disease patients do not have a treatment option at all. For those rare diseases where there is an approved pharmaceutical treatment, patients continue to be burdened by sub-optimal drug formulations. Aprecia’s ZipDose ® 3DP technology can formulate fast-melt pharmaceutical products, incorporating significantly higher amounts of active pharmaceutical ingredient than any other fast-melt technology on the market. As such, this advanced technology can uniquely overcome both pill burden and dysphagia – swallowing difficulties – both of which are life-long, daily issues for so many rare disease patients.”

“We are excited to work with the Cycle team, and we see important synergies in the companies’ shared mission to address unmet needs in patient care,” said Don Wetherhold, CEO of Aprecia. “Cycle specializes in orphan drugs - they have proven that they can deliver quality-of-life improvements to rare disease patients around the world. Aprecia is fully committed to applying its ZipDose ® 3DP printing technology to address real-world, daily issues faced by rare disease patients,” he continued.

About Aprecia

Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® Technology to transform the way people take medicine. Its first innovation, ZipDose® Technology can be combined with a wide variety of active pharmaceutical ingredients to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address unmet treatment needs to eliminate patient suffering and caregiver burden. For further information, please visit www.aprecia.com.

About Cycle Pharmaceuticals

Cycle is a pharmaceutical company that optimizes and increases access to existing pharmaceuticals. Specifically, Cycle focuses on three areas of pharmaceutical development:

- Improving orphan drugs, which treat the under-served rare disease patient community;

- Reinstating generic drug products that have been previously marketed; and

- Working with our academic and other partners to extend pharmaceuticals to new medical areas where there is clear unmet need.

Cycle’s first orphan drug product, NITYR™ (nitisinone) tablets, is approved in the U.S. and Canada for the treatment of hereditary tyrosinemia type-1.

The company’s global headquarters are in Cambridge, United Kingdom. For further information, please visit www.cyclepharma.com.

Contact information

FOR FURTHER INFORMATION AND INTERVIEWS PLEASE CONTACT
Aprecia Pharmaceuticals, LLC
Jennifer Zieverink, Senior Director Marketing & Alliance Management
Tel: +1 513 864 4114 (GMT-5)
E-mail: jennifer.zieverink@aprecia.com
Company Site: www.aprecia.com
or
Cycle Pharmaceuticals Ltd.
Paula Bekinschtein, Global Marketing Manager
Tel: +44 1223 803 636 (GMT)
Email: paula.bekinschtein@cyclepharma.com
Company Site: www.cyclepharma.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

GSMA Marks International Girls in ICT Day with Events around the World25.4.2018 11:00Tiedote

The GSMA will celebrate the annual ITU International Girls in ICT Day this week with a series of events across its global footprint aimed at encouraging and empowering young women to explore career opportunities in the science, technology, engineering and mathematics (STEM) areas and helping companies worldwide reap the benefits of greater female participation in the tech sector. The 2018 ITU International Girls in ICT Day will be held on Thursday 26 April and will be marked by events run by local GSMA offices in Atlanta, Barcelona, Brussels, Dubai, Hong Kong, London and Nairobi. “The GSMA is delighted to be supporting the ITU International Girls in ICT event for the fifth year running, inviting girls from around the world to learn about the rewarding careers possible within the mobile industry and the wider ICT sector,” said Mats Granryd, Director General, GSMA. “The future success of our industry rests on the ability to attract talented females and we hope to inspire a new generation

Kela: Contrary to Reports, the Basic Income Experiment in Finland Will Continue until the End of 201825.4.2018 10:31Tiedote

Many international media-outlets have published stories alleging that Finland is going to discontinue its basic income experiment. This information is incorrect. “The experiment is proceeding according to plan and will continue until the end of 2018”, says Professor Olli Kangas, the leader of the research team at Kela (Social Insurance Institution of Finland). There are currently no plans to continue or expand the experiment after 2018. The effects will be studied after the experiment has ended The employment effects across the whole experiment will be available by the end of 2019 or at the beginning of 2020. “The effects of the experiment will not be published while the experiment is in progress, because a public discussion of the results could influence the behaviour of the test and control groups. That would lead to skewed results”, Kangas says. The basic income experiment was launched in January 2017. During the experiment, the 2,000 participants are receiving a EUR 560 monthly bas

GSMA Announces Additional Keynote Speakers for Mobile World Congress Shanghai 201825.4.2018 10:00Tiedote

The GSMA today announced that executives from leading organisations across the mobile ecosystem will participate in the keynote programme at the 2018 GSMA Mobile World Congress Shanghai. The GSMA also announced the first speakers for the new Leaders Stage, as well as newly confirmed exhibitors, partners, sponsors and events. Mobile World Congress Shanghai will take place 27-29 June at the Shanghai New International Expo Centre (SNIEC). “With just over two months to go, we have a very exciting programme lined up for Mobile World Congress Shanghai 2018,” said Michael O’Hara, Chief Marketing Officer. “While showcasing the latest developments in mobile, this year’s event will offer attendees a wide range of experiences through the conference, the exhibition and specialised programmes such as Women4Tech, 4YFN and beyond.” New Keynote Speakers Confirmed The GSMA announced several additional keynote speakers for Mobile World Congress Shanghai, with executives from leading mobile operators, in

News Services Group Officially Announces the Rebranding of ME NewsWire to AETOSWire25.4.2018 10:00Tiedote

News Services Group (NSG) officially announces the rebranding of its news distribution arm ME NewsWire to AETOSWire. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180425005116/en/ Tony AbiHanna, President and CEO of NSG, AETOSWire and Esmaa News, explained the reason behind this timely move: “In 10 years, we have grown exponentially as a company. Middle East (ME) NewsWire as a name no longer encompasses the real essence and depth of our services. Hence, we handpicked a new brand name that we believe reflects who we are now and will continue to embody us in the future.” The name “AETOS” captures the heart and soul of the company’s services. It’s derived from Greek Mythology, AETOS DIOS, which translates to “The Eagle of Zeus.” AETOS is the Giant , Trusted, Loyal, Fast and Personal Messenger of Zeus, the very same characteristics that the company brings to its valued and esteemed clientele. Today, AETOSWire has the largest an

IAB Europe and IAB Tech Lab Release Cross-Industry Transparency & Consent Framework for Adoption25.4.2018 10:00Tiedote

IAB Europe and IAB Technology Laboratory today released the market-ready technical specifications for the Transparency & Consent Framework (“Framework”) following a 30-day public consultation in March and April 2018. The official release version of the standard reflects extensive feedback from publishers, agencies, and ad tech companies collected during the consultation period. As with all standards, it is expected that this standard will be iterated with new features and attributes in the future. The Framework allows users to have full authority over their data. The Framework is a cross-industry standard that supports online services and their partners in their efforts to provide transparency and choice mechanisms for their users. In accordance with the General Data Protection Regulation (GDPR), users can now be made aware of not only online services’ use of their users’ personal data, but also use of that data by third parties that assist online services in showing advertisements to

Digital Element Partners with Discovery Inc. to Enhance the Company’s Video Rights Accuracy with Location-Based Technology25.4.2018 10:00Tiedote

Digital Element, the global geolocation data and services provider, today announced that global media company, Discovery Inc., has adopted its NetAcuity hyperlocal IP geolocation technology, to ensure the right people see the right content and remain compliant with geographic rights across Europe. Discovery has a global reach of more than three billion viewers across more than 220 countries and territories and is home of leading TV offerings including Eurosport, Discovery Channel and Animal Planet, to name a few. The internationally-renowned brand reaches audiences across screens through digital-first programming from providers including Group Nine Media, Discovery VR, and Eurosport Player. European telecommunications companies often operate across numerous territories and distribute IP addresses to multiple regions, which can make the management of geographic TV rights complex. By adopting Digital Element's IP intelligence solution, NetAcuity, which enables the identification of the p

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme